In the BioHarmony Drug Report Database

"Preview" Icon

Caspofungin

Cancidas, Caspofungin Acetate, Caspofungin MSD (caspofungin) is a small molecule pharmaceutical. Caspofungin was first approved as Cancidas on 2001-01-26. It is used to treat aspergillosis, candidemia, and mycoses in the USA. It has been approved in Europe to treat aspergillosis and candidiasis. Cancidas’s patent is valid until 2032-12-21 (FDA).

 

Trade Name

 

Cancidas, Caspofungin MSD
 

Common Name

 

caspofungin
 

ChEMBL ID

 

CHEMBL499808
 

Indication

 

aspergillosis, candidemia, candidiasis, mycoses
 

Drug Class

 

Antifungal antibiotics (undefined group)

Image (chem structure or protein)

Caspofungin structure rendering